The CEO’s unexpected departure is part of the health information brand’s latest changes. On the table: possible acquisitions. In progress: a new federal contract and new website content. Ignored: if the company wants to be bought.
Business Briefs: Docs question Gleevec price, Sanofi pill may delay MS onset
April 25, 2013
5:17 pm
Doctors call out Novartis on drug prices; Aubagio shows strong top-line data in trials; and overseas docs increasingly turn to digital.
Business briefs: Allergan, Amgen, Wiley
February 5, 2013
5:22 pm
Allergan’s 2013 outlook scores points with at least one analyst, Amgen is laying off 160 staff, and Wiley renews a publishing relationship.
Pradaxa dominates doc poll of most effective journal ads
The most effective journal ads of the year included executions for Pradaxa, Humira and Conceptus’ Essure Procedure, according to the Doctors’ Choice Study.
Docs cozy up to brands that bring unique benefits, thought-leader backing
Physician trust in pharmaceutical brands is driven by an emotional connection as well as functional attributes and perceptions of the manufacturer, said Harris Interactive, which found Advair, Spiriva and Mirena to be tops in their categories with doctors.
Bayer’s Sandra Peterson jumps to J&J, takes on consumer
The alumna of Bayer’s crop, medical and diabetes units is taking on the title of group worldwide chairman, which comes with oversight of the global supply chain, IT and the troubled consumer unit.
New ad model fosters pharma’s leap to digital, publisher finds
Could an online quiz be the future of continuing medical education? In a twist on the “edu-gaming” phenomenon, Cleveland Clinic and physician site MDLinx aim to answer that question with The Smartest Doc, a daily one-minute quiz that aims to keep doctors up to date on the medical literature by appealing to their competitive spirit.